Skip to main content
OpenTrials

Clinical trial condition

Paroxysmal Nocturnal Hemoglobinuria

Explore clinical trials studying Paroxysmal Nocturnal Hemoglobinuria. Study availability and eligibility vary by location and protocol.

89 public trials 13 recruiting studies

Paroxysmal Nocturnal Hemoglobinuria trial results

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +20 more
Locations
  • Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
  • Moscow State Budget Funded Healthcare Institution S. P. Botkin City Clinical Hospital, Moscow Department of Healthcare Moscow, Russia
  • State Budget Funded Institution of Higher Education Academician I. P. Pavlov Saint-Petersburg State Medical University of the Ministry of Health of the Russian Federation Saint Petersburg, Russia
  • State Budgetary Educational Institution of Higher Professional Education Samara State Medical University, Ministry of Health of the Russian Federation. Samara, Russia
Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +9 more
Locations
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Chelyabinsk Oblast, Russia
  • Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency" Kirov, Kirov Oblast, Russia
  • Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I.P. Pavlov" Saint Petersburg, Leningradskaya Oblast', Russia
  • Federal State Budgetary Institution "National Medical Research Center of Hematology" of the Ministry of Health of the Russian Federation Moscow, Moscow Oblast, Russia
Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States